Wellgistics Health, Inc. (NASDAQ:WGRX) Short Interest Down 77.2% in June

Wellgistics Health, Inc. (NASDAQ:WGRX) was the recipient of a significant decrease in short interest in June. As of June 15th, there was short interest totaling 101,300 shares, a decrease of 77.2% from the May 31st total of 444,588 shares. Currently, 5.5% of the shares of the stock are short sold. Based on an average trading volume of 71,464 shares, the days-to-cover ratio is presently 1.4 days.

Wellgistics Health Stock Performance

NASDAQ WGRX opened at $3.02 on Monday. The business has a 50 day moving average price of $4.71 and a 200 day moving average price of $11.32. The company has a market capitalization of $7.58 million, a P/E ratio of -0.07 and a beta of -1.44. Wellgistics Health has a 1-year low of $2.81 and a 1-year high of $97.50. The company has a debt-to-equity ratio of 1.86, a current ratio of 0.09 and a quick ratio of 0.03.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. Raymond James Financial Inc. boosted its position in shares of Wellgistics Health by 593.8% in the 3rd quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock worth $52,000 after buying an additional 50,000 shares in the last quarter. XTX Topco Ltd grew its stake in Wellgistics Health by 195.1% in the 4th quarter. XTX Topco Ltd now owns 106,087 shares of the company’s stock valued at $42,000 after acquiring an additional 70,137 shares during the last quarter. Geode Capital Management LLC increased its holdings in Wellgistics Health by 81.0% during the 4th quarter. Geode Capital Management LLC now owns 487,383 shares of the company’s stock valued at $195,000 after acquiring an additional 218,170 shares in the last quarter. Finally, Heights Capital Management Inc. purchased a new position in Wellgistics Health during the 3rd quarter valued at about $2,588,000.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on WGRX. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Wellgistics Health in a research note on Wednesday. Wall Street Zen raised shares of Wellgistics Health to a “sell” rating in a report on Saturday, May 30th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

Wellgistics Health Company Profile

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.